Vascular targeting of solid tumours: a major ‘inverse’ volume–response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas
- 30 September 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (14) , 1833-1843
- https://doi.org/10.1016/s0959-8049(00)00173-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Rocking the foundations of solid tumor growth by attacking the tumor's blood supplyImmunology Today, 1998
- A flanking attack on cancerNature Medicine, 1998
- Designing Therapies That Target Tumor Blood VesselsScience, 1997
- Angiostatin induces and sustains dormancy of human primary tumors in miceNature Medicine, 1996
- Inhibition of Tumor AngiogenesisAnnals of the New York Academy of Sciences, 1994
- Angiogenesis inhibition: A reviewPharmacology & Therapeutics, 1994
- Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapyThe British Journal of Radiology, 1993
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Vascular Endothelium as the Vulnerable Element in TumoursActa Radiologica: Oncology, 1984
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971